ALGORITM VYBORA TERAPII PRI LEChENII DISMENOREI V RAMKAKh KONSUL'TIROVANIYa V APTEKE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the current understanding of the mechanisms of dysmenorrhea and main pharmacological approaches to relief of its symptoms, which include the use of non-steroidal anti-inflammatory drugs, estrogen-progestin preparations, antispasmodics and combination drugs. The data on the efficacy and safety of drugs traditionally used to relief of menstrual pain are presented. The alternative methods of treatment of dysmenorrhea are considered. The algorithm for choosing a drug for the treatment of dysmenorrhea in the counseling of patients at the pharmacies is suggested.

Full Text

Restricted Access

References

  1. Гинекология. Национальное руководство / Под ред. В.И. Кулакова, Г.М. Савельевой, И.Б. Манухина. М., 2009. 1088 с.
  2. Unsal A, Ayrancl U, Tozun M, et al. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students Ups J Med Sci 2010;115: 138-45.
  3. Singh A, Kiran D, Singh H, Nel B. Prevalence and severity of dysmenorrheal: a problem related to menstruation, among first and second year female medical students. J Physiol Pharmacol 2008;52(4):389-97.
  4. Weissman AM, Hartz AJ, Hansen MD, Johnson SR. The natural history of primary dysmenorrheal: a longitudinal study. BJOG 2004;111(4):345-52.
  5. Филиппова О.В., Черкасова Н.Ю. Потребительские предпочтения при дисменорее// Фармация 2012.№ 1. С. 22-6.
  6. Хороших Н.В., Филиппова О.В., Черкасова Н.Ю. и др. Анализ зависимости тяжести первичной альгодисменореи от особенностей менструальной функции и росто-весовых показателей // Системный анализ и управление в биомедицинских системах 2010. № 9(2). С. 427-30.
  7. Rodrigues AC, Gala S, Neves A, et al. Dysmenorrhea in adolescents and young adults: prevalence, related factors and limitations in daily living. Acta Med Port 2011;24(Suppl.2):383-88.
  8. Allen LM, Lam AC. Premenstrual syndrome and dysmenorrhea in adolescents. Adolesc Med State Art Rev 2012;23(1):139-63.
  9. Kitamura M, Taceda T, Koga S, et al. Relationship between premenstrual symptoms and dysmen-orrheal in Japanese high school students. Arch WomensMent Health 2012;15(2):131-33.
  10. Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. doi:10 2006.
  11. Манушарова Р.А., Черкезова Э.И. Гинекологическая эндокринология: руководство для врачей. М., 2008. 280 с.
  12. Руководство по эндокринной гинекологии / Под ред. Е.М. Вихляевой. 3-е изд., доп. М., 2006. 784 с.
  13. Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. М., 2004. 528 с.
  14. Sales JK, Henry NJ. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003;126(5):559-67.
  15. Lefebvre G, Pinsonneault O, Antao V, et al. Primary dysmenorrhea consensus guideline. Obstet Gynaecol Can 2005;27(12):1117-46.
  16. Лекарственные средства, применяемые в акушерстве и гинекологии. 2-е изд., испр. и доп. / Под ред. Кулакова В.И. и др. М., 2006. 384 с.
  17. Рациональная фармакотерапия в акушерстве и гинекологии. Руководство для практикующих врачей / Под ред. B.И. Кулакова и др. М., 2005. 1151 с.
  18. Latthe PM, Champaneria R, Khan KS. Dysmenorrhea. Clin Evid. 2011;2011. pii:0813
  19. Пахомова И.Г. Место нестероидных противовоспалительных средств в гинекологической практике (рациональный выбор препаратов с учетом побочных эффектов) // Фарматека 2009. № 9. C. 45-49.
  20. Серов В.Н., Уварова Е.В., Гайнова И.Г. Современные возможности использования нестероидных противовоспалительных средств для устранения и профилактики дисменореи // Фарматека 2004. № 15. С. 18-24.
  21. Ong CKS, Lirk P, Tan CH. et al. An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs. Clin Med Res 2007;5(1):19-34.
  22. Dawood MY. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrheal. Am J Med 1988;84(5A0):23-9.
  23. Тихомиров А.Л., Лубнин Д.М. Нурофен в лечении первичной дисменореи // РМЖ 2002. № 7. С. 344-46.
  24. Colombo F, Gangemy D, Garatta L. et al. Comparative evaluation of the efficacy of naproxen sodium and ibuprofen in the treatment of primary dysmenorrheal. Ann Jstet Gunecol Med Perinat 1990;111930:205-08.
  25. Mehlisch DR. Double-blind crossover comparison of ketoprofen, naproxen, and placebo in Современная фармакология предлагает достаточно большой выбор лекарственных средств для устранения боли при менструации. В качестве стартовой терапии оптимален вариант выбора дротаверина, обладающего хорошим профилем безопасности. patients with ptimary dysmenorrheal. Clin Ther 1990;12(5):398-409.
  26. Milsom I, Minic M, Dawood MY, et al. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrheal: a pooled analysis of five studies. Clin Ther 2002;24990:1384-400.
  27. Pasquale SA, Rathauser R, Dolese HM. A doubl-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrheal. Am J Med 1988;84(5A):30-4.
  28. Rainsford KD. Ibuprofen: from invention to OTC therapeutic mainstay. Int J Clin Pract 2013;178(Suppl):9-20.
  29. Филиппова О.В., Черкасова Н.Ю. Фармацевтическое консультирование пациенток с дисменореей// Фармация 2011. № 5. С. 31-5.
  30. Thomas P. Connolly Cyclooxygenase-2 Inhibitors in Gynecologic Practice Clinical Medicine & Research 2003;1(2):105-10.
  31. Каратеев А.В. Нимесулид во втором десятилетии XXI века // Consilium medicum 2012. № 14(2). С. 104-11.
  32. Moore A, Makinson G, Li C. Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51000 patients enrolled in 52 randomized trials. Arthritis Res Ther 2013;15(1):R6.
  33. Daniels S, Robbins J, West CR, et al. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. Clin Ther 2009;31(6):1192-208.
  34. Eccles R, Holbrook A, Jawad M. A doubleblind, randomized, crossover study of two doses of a single-tablet combination of ibuprofen/ paracetamol and placebo for primary dysmen-orrheal. Curr Med Res Opin 2010;26(11): 2689-99.
  35. Ушкалова Е.Н., Астахова А.В. Проблемы безопасности анальгина // Фарматека 2003. № 1. С. 74-9.
  36. Kido A, Togashi K, Kataoka M, et al. The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging. Human Reproduction 2007;22(7):2066-71.
  37. Dmitrovic R, Kunselman AR, Legro RS. Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol. 2012;119(6):1143-50.
  38. Harada T, Momoeda M, Terakawa N, et al. Evaluatin of low-dose oral contraceptive pill for primary dysmenorrheal: a placepo-controlled, double-blind, randomized trial. Fertil Steril 2011;95(6):1928-31.
  39. Lindh I, Ellstrom AA, Milsom I. The effect of combined oral contraceptives and age on dys-menorrhoea: an epidemiological study. Hum Reprod 2012;27(3):676-82.
  40. Strowitzki T, Kirsch B, Elliesen J. Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care 2012;38(2):94-101.
  41. Brown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 2012;3:CD002122.
  42. Джобава Э.М., Мандрыкина Ж.А., Логинова К.Б. и др. Дисменорея. Этопатогенез, дифференциальная диагностика и терапия в практике современного акушера-гинеколога // РМЖ 2012. № 1. С. 28-35.
  43. Инструкция по медицинскому применению препарата Но-шпа РУ П N011854/02-160611
  44. Debski R, Niemiec T, Mazurek M, et al. Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhoea - protocol DOROTA. Ginecol pol 2007;78(12):933-38.
  45. Tar A, Singer J. Safety profile of NO-SPA®. Orv. Hetil 2002;143:559-62.
  46. Santos AR, Zmijanovich R, Perez Macri S, et al. Antispasmodic/analgesic associations in primary dysmenorrhea double-blind crossover placebocontrolled clinical trial. Int J Clin Pharmacol Res 2001;21(1):21-9.
  47. Kryzhanivskii GN, Bakuleva LP, Luzina NL, et al. Endogenous opioid system in the realization of the analgesic effect of alfa-tocopherol in reference to algomenorrhea. Biull Eksp Biol Med 1988;105(2):148-50.
  48. Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician. 2009;80(2):157-62.
  49. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001;(3):CD002124.
  50. Rahbar N, Asgharzadeh N, Ghorbani R. Effect of omega-3 fatty acids on intensity of primary dysmenorrheal. Int J Gynaecol Obstet 2012;117(1):45-7.
  51. Tokuyama S, Nakamoto K. Unsaturated fatty acids and pain. Biol Pharm Bull 2011;34(8):1174-78.
  52. Fedorowicz Z, Nasser M, Jagannath VA, et al. Beta2-adrenoceptor agonists for dysmenorrhoea. Cochrane Database Syst Rev 2012;5:CD008585.
  53. Mirabi P, Dolatin M, Mojab F, et al. Effects of valerian on the severity and systemic manifestations of dysmenorrheal. Int J Gynaecol Obstet 2011;115(3):285-88.
  54. Rahnama P, Montazeri A, Huseini FH, et al. Effect of Zingeber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrheal: a placebo randomized trial. BMC Complement Altern Med 2012;12(1):92.
  55. Rakhashaee Z. Effect of three yoga poses (cobra, cat and fish) in women with primary dysmenorrheal: a randomized clinical trial. J. Pediatr Adolesc Gynecol 2011;24(4):192-96.
  56. Ernst E, Lee MS, Choi TY. Acupuncture in obstetrics and gynecology: an overview of systematic reviews. Am J Chin Med 2011;39(3):423-31.
  57. Smith CA, Crowther CA, Petrucco O, et al. Acupuncture to treat primary dysmenorrheal in women: a randomized controlled trial. Evid Based Complement Alternat Med 2011;2011:612464.
  58. Valiani M, Ghasemi N, Bahadoran P, et al. The effects of massage therapy on dysmenorrheal caused by endometriosis. Iran J Nurs Midwifery Res 2010;15(4):167-71.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies